Home › Targets › alpha-synuclein

alpha-synuclein (2 companies · 6 programs)

Companies with an active program directed at alpha-synuclein.

AC Immune SA ACIU

ACI-7104.056 — Parkinson's Disease Phase 2
ACI-12589 — Multiple System Atrophy Phase 1
ACI-15916 — Parkinson's Disease Phase 1

ProMIS Neurosciences Inc. PMN

PMN442 — Multiple System Atrophy Preclinical
PMN442 — Dementia with Lewy Bodies Preclinical
PMN442 — Parkinson's Disease Preclinical